FAP and neoplasm: Specificity towards FAP of both compounds was demonstrated by pre-injection of 100 nmol FAPI-04 resulting in an almost complete lack of uptake (> − 90%, Supplementary Fig. 16) in the hFAP-HT1080 tumor for [68Ga]Ga-NODAGA-FAP647.